JP2000516610A5 - - Google Patents

Download PDF

Info

Publication number
JP2000516610A5
JP2000516610A5 JP1998509841A JP50984198A JP2000516610A5 JP 2000516610 A5 JP2000516610 A5 JP 2000516610A5 JP 1998509841 A JP1998509841 A JP 1998509841A JP 50984198 A JP50984198 A JP 50984198A JP 2000516610 A5 JP2000516610 A5 JP 2000516610A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998509841A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000516610A (ja
JP4393587B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/013816 external-priority patent/WO1998006380A2/en
Publication of JP2000516610A publication Critical patent/JP2000516610A/ja
Publication of JP2000516610A5 publication Critical patent/JP2000516610A5/ja
Application granted granted Critical
Publication of JP4393587B2 publication Critical patent/JP4393587B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP50984198A 1996-08-16 1997-08-08 医薬の上昇性投与量を提供するための薬剤投与型 Expired - Lifetime JP4393587B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2328696P 1996-08-16 1996-08-16
US60/023,286 1996-08-16
PCT/US1997/013816 WO1998006380A2 (en) 1996-08-16 1997-08-08 Dosage form for providing ascending dose of drug

Publications (3)

Publication Number Publication Date
JP2000516610A JP2000516610A (ja) 2000-12-12
JP2000516610A5 true JP2000516610A5 (Direct) 2005-04-07
JP4393587B2 JP4393587B2 (ja) 2010-01-06

Family

ID=21814183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50984198A Expired - Lifetime JP4393587B2 (ja) 1996-08-16 1997-08-08 医薬の上昇性投与量を提供するための薬剤投与型

Country Status (13)

Country Link
EP (1) EP0957899B1 (Direct)
JP (1) JP4393587B2 (Direct)
CN (2) CN101518517B (Direct)
AT (1) ATE234602T1 (Direct)
AU (1) AU3909597A (Direct)
CA (1) CA2263558A1 (Direct)
CY (1) CY2475B1 (Direct)
DE (1) DE69720055T2 (Direct)
DK (1) DK0957899T3 (Direct)
ES (1) ES2194210T3 (Direct)
PT (1) PT957899E (Direct)
WO (1) WO1998006380A2 (Direct)
ZA (1) ZA977254B (Direct)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
EP1690531A3 (en) * 1996-09-30 2010-01-20 Alza Corporation Dosage form and method for administering drug
PT932388E (pt) * 1996-09-30 2006-07-31 Alza Corp Forma de dosagem e metodo para administracao de farmacos
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
ES2264173T3 (es) * 1996-11-25 2006-12-16 Alza Corporation Forma de dosificacion para suministrar una dosis creciente.
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
KR100890537B1 (ko) * 1998-06-03 2009-03-27 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
KR100827254B1 (ko) * 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
AU2004200938B2 (en) * 1998-06-03 2006-09-14 Alza Corporation Methods and devices for providing prolonged drug therapy
AU2012232984B2 (en) * 1998-06-03 2015-10-29 Alza Corporation Methods and devices for providing prolonged drug therapy
ATE277594T1 (de) * 1998-06-03 2004-10-15 Alza Corp Vorrichtungen um eine verlängerte medikamententherapie zu erreichen
CN100444830C (zh) 1998-11-02 2008-12-24 伊兰公司，Plc 多颗粒改进释放组合物
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
EP1191924A4 (en) 1999-04-06 2005-02-09 Pharmaquest Ltd PHARMACEUTICAL DOSAGE FORM FOR INTERMITTENT ADMINISTRATION OF (D-THREO) -METHYLPHENIDATE AND A SECOND STIMULANT OF THE CENTRAL NERVOUS SYSTEM
HK1053060A1 (zh) * 2000-01-20 2003-10-10 德尔西斯药品公司 多级药物剂型
RU2321391C2 (ru) * 2002-07-29 2008-04-10 Алза Корпорейшн Способы и лекарственные формы для контролируемой доставки палиперидона
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20040091538A1 (en) * 2002-10-31 2004-05-13 Crystal Pollock-Dove Dosage form providing ascending release of liquid formulation
US7988993B2 (en) 2002-12-09 2011-08-02 Andrx Pharmaceuticals, Inc. Oral controlled release dosage form
MXPA06003452A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente.
KR20060092255A (ko) 2003-09-26 2006-08-22 알자 코포레이션 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
PL116330U1 (en) 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
WO2015001488A1 (en) 2013-07-01 2015-01-08 Ranbaxy Laboratories Limited Extended-release tablets of paliperidone and processes of preparation thereof
CA2936740C (en) 2014-10-31 2017-10-10 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
WO2017115328A1 (en) * 2015-12-31 2017-07-06 Cadila Healthcare Limited Extended release osmotic dosage form comprising high methylphenidate hydrochloride load
EP3501504A1 (en) 2017-12-22 2019-06-26 Pharmacia Polonica sp. z o.o. Modified release tablet of paliperidone and a process for the preparation thereof
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US5017381A (en) * 1990-05-02 1991-05-21 Alza Corporation Multi-unit pulsatile delivery system
DK0621032T3 (da) * 1993-04-23 2000-10-23 Novartis Ag Lægemiddelform med reguleret afgivelse
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation

Similar Documents

Publication Publication Date Title
JP2000502280A5 (Direct)
JP2000501771A5 (Direct)
JP2000501599A5 (Direct)
JP2000501018A5 (Direct)
JP2000500076A5 (Direct)
JP2000501324A5 (Direct)
JP2000502472A5 (Direct)
JP2000501338A5 (Direct)
JP2000501825A5 (Direct)
JP2000500874A5 (Direct)
JP2000502485A5 (Direct)
JP2000502425A5 (Direct)
JP2000502568A5 (Direct)
JP2000501774A5 (Direct)
JP2000506134A5 (Direct)
JP2000500912A5 (Direct)
JP2000502570A5 (Direct)
JP2000501876A5 (Direct)
JP2000501744A5 (Direct)
JP2000516610A5 (Direct)
JP2000501229A5 (Direct)
JP2000502316A5 (Direct)
JP2000500857A5 (Direct)
JP2000502714A5 (Direct)
JP2000501569A5 (Direct)